14 February 2017 1 Min Read
Adcock Ingram expects earnings to jump by half
The Bidvest-linked pharmaceuticals group appears to have turned a corner in 2017
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In